Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease

Thumbnail
Fulltext:
224636.pdf
Size:
966.5Kb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2020
Author(s)
Gommans, D.H.F.
Nas, J.
Pinto-Sietsma, S.J.
Koop, Y.
Konst, R.E.
Mensink, F.B.
Aarts, G.W.A.
Konijnenberg, L.S.F.
Cortenbach, K.R.
Verhaert, D.V.M.
Thannhauser, J.
Mol, J.H.Q.
Rooijakkers, M.J.P.
Vos, J.L.
Rumund, A. van
Vart, P.
Hassing, R.J.
Cornel, J.H.
Jager, C.P.C. de
Heuvel, M. van den
Hoeven, J.G. van der
Royen, N. van
Kimmenade, R.R.J. van
Source
American Heart Journal, 226, (2020), pp. 60-68
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/224636   https://hdl.handle.net/2066/224636
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.